DSC Advisors, L.P.
- SEC CIK
- 0001299434
- Latest filing
- Nov 14, 2024
BMRN holding history
Biomarin Pharmaceutical Inc in every 13F filed by DSC Advisors, L.P., including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.
BMRN overviewAll 13F holders of BMRNFull Q3 2024 holdings
- Shares (Q2 2024)
- 0
- Sold out in Q2 2024
- Value
- $0
- % of portfolio
- 0.0%
- Quarters held
- 10
- Since Q4 2021
| Quarter | Shares | Value | % of portfolio | Share change | Action | All holders |
|---|---|---|---|---|---|---|
| Q2 2024 | 0 | $0 | 0.0% | −99,000−100.0% | Sold out | Holders |
| Q1 2024 | 99,000 | $8.65M | 14.0% | −1,000−1.0% | Reduced | Holders |
| Q4 2023 | 100,000 | $9.64M | 16.4% | 00.0% | Unchanged | Holders |
| Q3 2023 | 100,000 | $8.85M | 13.2% | 00.0% | Unchanged | Holders |
| Q2 2023 | 100,000 | $8.67M | 13.6% | +7,500+8.1% | Added | Holders |
| Q1 2023 | 92,500 | $8.99M | 17.1% | +10,000+12.1% | Added | Holders |
| Q4 2022 | 82,500 | $8.54M | 19.6% | 00.0% | Unchanged | Holders |
| Q3 2022 | 82,500 | $6.99M | 7.5% | 00.0% | Unchanged | Holders |
| Q2 2022 | 82,500 | $6.84M | 6.9% | +2,500+3.1% | Added | Holders |
| Q1 2022 | 80,000 | $6.17M | 4.9% | +10,000+14.3% | Added | Holders |
| Q4 2021 | 70,000 | $6.18M | 7.1% | +70,000 | New | Holders |